Evercore ISI analyst Glenn Schorr maintained a Buy rating on Goldman Sachs Group (GS – Research Report) yesterday and set a price target of ...

Bank of New York Mellon (NYSE:BK – Get Free Report)‘s stock had its “sector perform” rating reissued by stock analysts at ...

The investment bank said Bio-Techne is a premium growth asset with a strong core business and growth verticals.

Fintel reports that on March 18, 2025, Evercore ISI Group initiated coverage of West Pharmaceutical Services (NYSE:WST) with ...

Fintel reports that on March 18, 2025, Evercore ISI Group initiated coverage of Repligen (NasdaqGS:RGEN) with a In-Line ...

Evercore ISI analyst Glenn Schorr maintained a Hold rating on Invesco (IVZ – Research Report) yesterday and set a price target of $18.00. The ...

Bank of New York Mellon Corp grew its position in Travere Therapeutics, Inc. (NASDAQ:TVTX – Free Report) by 3.6% in the 4th quarter, according to its most recent disclosure with the Securities and ...

Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic kidney disease (CKD), obstructive sleep apnea ...

Evercore (EVR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. NEW YORK, March 04, 2025--Evercore Wealth Management today announced ...

St., the hotel is directly across the street from the Port Authority Bus Terminal and its constant convoy of Greyhounds. But ...

WASHINGTON, NEW YORK] Oracle is weighing a proposal for a sale of TiKTok’s US operations that would have it provide security assurances and take a small stake in a new American entity while ...

In this article, we’ll take an in-depth look at the 15 stocks with the most insider sales in the last quarter.